Cancer Immunotherapy Using RNA Aptamers for Cell-Selective Delivery or Intracellular Target Inhibition
Time: 11:30 am
day: Conference Day Two
Details:
- Expanding therapeutic horizons of aptamers beyond conventional targets on cell surface
- Leveraging innovative oligonucleotide chemistries to enable novel cancer treatment strategies
- Advancing conjugation technologies to enhance delivery and address complex myeloid cell biology